Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Quarterly results
Appointed director

ADIAL PHARMACEUTICALS, INC. (ADIL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Bought 700 shares @ $2.74, valued at $1.9k
06/02/2023 4 Johnson Bankole A. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $0.3025, valued at $12.1k
05/25/2023 4 Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 157,500 shares @ $0
Granted 125,000 options to buy @ $0.3025, valued at $37.8k
05/25/2023 4 Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 240,800 shares @ $0
Granted 50,000 options to buy @ $0.3025, valued at $15.1k
05/25/2023 4 Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $0.3025, valued at $15.1k
05/25/2023 4 Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $0.3025, valued at $15.1k
05/25/2023 4 Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $0.3025, valued at $15.1k
05/25/2023 4 Gilliland Robertson H. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $0.3025, valued at $15.1k
05/25/2023 4 Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 420,000 shares @ $0
Granted 300,000 options to buy @ $0.3025, valued at $90.8k
05/25/2023 4 Anderson J. Kermit (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 50,000 options to buy @ $0.3025, valued at $15.1k
01/03/2023 4 Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Disposed/sold 166,667 shares @ $0
09/20/2022 4 Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 25,000 shares @ $0.4294, valued at $10.7k
Granted 75,000 shares @ $0.4202, valued at $31.5k
08/23/2022 4 Stilley William B. III (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 100,000 options @ $0.555, valued at $55.5k
08/22/2022 4 Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 1,000,000 shares @ $0
06/28/2022 4 Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 25,000 options @ $1.23, valued at $30.8k
02/25/2022 4 Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 35,000 options to buy @ $2, valued at $70k
02/25/2022 4 Goodman Tony (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $2, valued at $80k
02/25/2022 4 Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 100,000 options to buy @ $2, valued at $200k
02/25/2022 4 Stilley William B. III (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 250,000 shares @ $0
02/25/2022 4 Schuyler Kevin (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $2, valued at $80k
02/25/2022 4 Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $2, valued at $80k
02/25/2022 4 Gilliland Robertson H. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $2, valued at $80k
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Anderson J. Kermit (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 40,000 options @ $2, valued at $80k
01/03/2022 4 Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Bought 10,000 shares @ $2.66, valued at $26.6k
Bought 5,000 shares @ $2.72, valued at $13.6k
Bought 10,000 shares @ $2.71, valued at $27.1k
12/23/2021 4 Schuyler Kevin (10% Owner) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Gifted 312,990 shares @ $0
Gifted 90,000 options to buy @ $6.25, valued at $562.5k
12/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2021 4 Stilley William B. III (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Bought 10,000 shares @ $2.5892, valued at $25.9k
Bought 10,600 shares @ $2.7527, valued at $29.2k
11/30/2021 4 Newman James W. Jr. (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Bought 10,000 shares @ $2.85, valued at $28.5k
11/03/2021 4 Claiborne Cary J (Director) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 60,000 options @ $3.15, valued at $189k
10/06/2021 4 Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Sold 200,000 shares @ $0
Disposed of 150,000 warrants @ $0
04/08/2021 4 Johnson Bankole A. (Chief Medical Officer) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Sold 150,000 shares @ $2.5, valued at $375k
02/10/2021 4 Truluck Joseph (CFO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 125,000 options to buy @ $3.11, valued at $388.8k
02/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy